X-ray crystallography

Crystal Structure Determination in Solid Form Drug Development, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Friday, September 11, 2020

Single crystal structure solution using X-ray diffraction analysis (SC-XRD) plays an important role in drug development.

Key Points: 
  • Single crystal structure solution using X-ray diffraction analysis (SC-XRD) plays an important role in drug development.
  • SC-XRD fully elucidates the molecular structure and can be used to confirm successful chemical synthesis of the molecule.
  • For more information or to register for this event, visit Crystal Structure Determination in Solid Form Drug Development .
  • Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

Proteros launches new cryo-EM facility to speed drug discovery

Retrieved on: 
Wednesday, September 9, 2020

Proteros also announced the formation of a cryo-EM consortium that will offer industry partners dedicated access to microscope time and preferred access to Proteros' protein science capabilities.

Key Points: 
  • Proteros also announced the formation of a cryo-EM consortium that will offer industry partners dedicated access to microscope time and preferred access to Proteros' protein science capabilities.
  • This initiative will advance cryo-EM toward routine application in drug discovery by enabling the study of proteins not accessible by x-ray crystallography."
  • Cryo-EM customers will benefit from Proteros' scientific insight and problem-solving approach for difficult drug discovery targets.
  • Proteros, Martinsried/Munich, Germany is a private biotechnology company providing drug discovery support for technically demanding drug targets.

Proteros launches new cryo-EM facility to speed drug discovery

Retrieved on: 
Wednesday, September 9, 2020

Proteros also announced the formation of a cryo-EM consortium that will offer industry partners dedicated access to microscope time and preferred access to Proteros' protein science capabilities.

Key Points: 
  • Proteros also announced the formation of a cryo-EM consortium that will offer industry partners dedicated access to microscope time and preferred access to Proteros' protein science capabilities.
  • This initiative will advance cryo-EM toward routine application in drug discovery by enabling the study of proteins not accessible by x-ray crystallography."
  • Cryo-EM customers will benefit from Proteros' scientific insight and problem-solving approach for difficult drug discovery targets.
  • Proteros, Martinsried/Munich, Germany is a private biotechnology company providing drug discovery support for technically demanding drug targets.

The August 2020 Edition of the Crystallography Times Newsletter is Available Online

Retrieved on: 
Friday, August 21, 2020

THE WOODLANDS, Texas, Aug. 21, 2020 /PRNewswire-PRWeb/ --The August edition of Crystallography Times from Rigaku Corporation has been published and is now available on the company's global website.

Key Points: 
  • THE WOODLANDS, Texas, Aug. 21, 2020 /PRNewswire-PRWeb/ --The August edition of Crystallography Times from Rigaku Corporation has been published and is now available on the company's global website.
  • Crystallography Timesan electronic newsletter published by Rigaku focusing on single crystal X-ray diffractionserves the X-ray analysis community, presenting current news and crystallographic research.
  • The latest issue of Crystallography Times introduces the new Rigaku XtaLAB Synergy Flow system, designed to enhance productivity and enable social distancing by providing unattended data acquisition and standardized workflow to the research environment.
  • The August Crystallography Times also offers useful links to relevant blogs and tutorials, featured videos and access to the Rigaku Oxford Diffraction user forum.

Rigaku Introduces New X-ray Diffraction System with Intelligent Workflow Automation

Retrieved on: 
Thursday, August 20, 2020

The new Rigaku XtaLAB Synergy Flow system was first announced in the August edition of Crystallography Times, the electronic newsletter published by Rigaku focusing on single crystal X-ray diffraction.

Key Points: 
  • The new Rigaku XtaLAB Synergy Flow system was first announced in the August edition of Crystallography Times, the electronic newsletter published by Rigaku focusing on single crystal X-ray diffraction.
  • The new diffractometer system features an integrated sample-changing automation platform, designed to improve research workflow.
  • Rigaku XtaLAB Synergy diffractometers are known for high-performance X-ray sources and direct X-ray detection detectors, a combination designed for high throughput.
  • The system utilizes the Intelligent Goniometer Head ( IGH ), a motorized automated goniometer head with fast response and built in intelligence.

Schrödinger and Viva Biotech Announce Strategic Collaboration to Generate and Interrogate Structures for Unsolved Targets

Retrieved on: 
Tuesday, July 28, 2020

Schrdinger, Inc. (Nasdaq: SDGR) and Viva Biotech Holdings (1873.HK) today announced a strategic collaboration to expand the reach of structure-based drug discovery by generating de novo crystal structures of high-value targets.

Key Points: 
  • Schrdinger, Inc. (Nasdaq: SDGR) and Viva Biotech Holdings (1873.HK) today announced a strategic collaboration to expand the reach of structure-based drug discovery by generating de novo crystal structures of high-value targets.
  • Viva Biotech will deploy X-ray crystallography designed to structurally enable these targets by generating high-resolution structures with bound ligands.
  • This collaboration brings together two leaders in the field of structure-based drug discovery, said Zhixiong Ye, Chief Scientific Officer at Viva Biotech.
  • Our expertise in x-ray crystallography and in other key related areas enables us to generate de novo structures for previously unsolved targets.

The July edition of the Crystallography Times newsletter is now online

Retrieved on: 
Thursday, July 23, 2020

THE WOODLANDS, Texas, July 23, 2020 /PRNewswire-PRWeb/ --The July edition of Crystallography Times from Rigaku Corporation has been published and is now available on the company's global website.

Key Points: 
  • THE WOODLANDS, Texas, July 23, 2020 /PRNewswire-PRWeb/ --The July edition of Crystallography Times from Rigaku Corporation has been published and is now available on the company's global website.
  • Crystallography Times - an electronic newsletter published by Rigaku focusing on single crystal X-ray diffraction - serves the X-ray analysis community, presenting current news and crystallographic research.
  • The new issue begins with a recap of the Asia-Pacific Edition of the Rigaku School for Practical Crystallography, a series of one-hour webinars held July 6-10 and July 13-17.
  • Information about the upcoming American Crystallographic Association virtual conference, as well as the Rigaku Single Crystal Online Users' Meeting, is also presented.

Protein Crystallization & Crystallography Market by Technology, Product & Service, Consumable, End-user, and Region - Global Forecast to 2025 - ResearchAndMarkets.com

Retrieved on: 
Thursday, July 9, 2020

The "Protein Crystallization & Crystallography Market by Technology (NMR, X-Ray Crystallography), Product & Service (Instrument (Liquid Handling (Automated)), Consumable (Reagent, Microplate) End User, and Region - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Protein Crystallization & Crystallography Market by Technology (NMR, X-Ray Crystallography), Product & Service (Instrument (Liquid Handling (Automated)), Consumable (Reagent, Microplate) End User, and Region - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
  • Consumables segment accounted for the largest share of the protein crystallization and crystallography market, by product and service, in 2019.
  • Based on product and service, the protein crystallization and crystallography market is segmented into consumables, instruments, and software and services.
  • In 2019, the consumables segment accounted for the largest share of the protein crystallization and crystallography market.

The June 2020 edition of the Crystallography Times newsletter is online

Retrieved on: 
Friday, June 19, 2020

THE WOODLANDS, Texas, June 19, 2020 /PRNewswire-PRWeb/ --The June edition of Crystallography Times from Rigaku Corporation has been published and is now available on the company's global website.

Key Points: 
  • THE WOODLANDS, Texas, June 19, 2020 /PRNewswire-PRWeb/ --The June edition of Crystallography Times from Rigaku Corporation has been published and is now available on the company's global website.
  • Crystallography Times is an electronic newsletter published by Rigaku focusing on single crystal X-ray diffraction.
  • The new issue begins with a recap of the first edition of the Rigaku School for Practical Crystallography, for which over 1200 students from over 60 countries pre-registered.
  • "Crystallography in the News" presents the latest research findings in protein and small molecule crystallography and X-ray diffraction.

The May 2020 edition of the Crystallography Times newsletter is online

Retrieved on: 
Saturday, May 23, 2020

THE WOODLANDS, Texas, May 23, 2020 /PRNewswire-PRWeb/ -- The May edition of Crystallography Times from Rigaku Corporation has been published and is now available on the company's global website.

Key Points: 
  • THE WOODLANDS, Texas, May 23, 2020 /PRNewswire-PRWeb/ -- The May edition of Crystallography Times from Rigaku Corporation has been published and is now available on the company's global website.
  • Crystallography Times is an electronic newsletter published by Rigaku, focusing on single crystal X-ray diffraction.
  • "Crystallography in the News" is a collection of recent news and developments, featuring the latest research findings in protein and small molecule crystallography and X-ray diffraction from around the world.
  • A new product, the Rigaku Intelligent Goniometer Head ( IGH ), is announced in the newsletter.